Document is current
Any future updates will be listed below
-
Authors
Cipria, Deborah https://orcid.org/0009-0006-0398-8386
Baccega, Tania
Rizzo, Miriana https://orcid.org/0009-0009-8094-8646
Quarato, Piergiuseppe https://orcid.org/0000-0003-3839-3383
Reschigna, Alice https://orcid.org/0009-0009-2207-2041
El Khoury, Rita https://orcid.org/0009-0000-9688-7336
Cappelluti, Martino Alfredo https://orcid.org/0000-0003-1948-0772
Ammann, Sandra https://orcid.org/0000-0003-0385-1890
Poeta, Valeria Mollica
Conti, Matteo https://orcid.org/0000-0003-3109-4073
Valsoni, Sara https://orcid.org/0000-0002-0512-1376
Spinelli, Pietro
Merelli, Ivan
Cathomen, Toni https://orcid.org/0000-0002-7757-4630
Casucci, Monica https://orcid.org/0000-0003-4500-9060
Lombardo, Angelo https://orcid.org/0000-0001-8262-042X
-
Funding
Funding for this research was provided by:
Fondazione Telethon
nChroma Bio
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 22 April 2026
First Online: 8 May 2026
Competing interests
: A.L. is a co-founder, equity holder, and consultant of nChroma Bio, a company developing epigenome editing applications. P.S. was an employee of nChroma Bio at the time the work was conducted and holds an equity interest in the company. A.L., D.C., T.B., A.R., and M.A.C. are inventors on patent applications related to the development of the polyfunctional editing strategy and improved ETR design, filed by IRCCS Ospedale San Raffaele and Fondazione Telethon ETS or by nChroma Bio. All other authors have no competing interests.
